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journal homepage: www.urol-sci .comEditorial commentKetamine-induced uropathy: All physicians be awareKetamine has been used as an anesthesia agent since the 1960s
and as a “recreational drug” for at least the past 2 decades, partic-
ularly in nightclubs, because of its well-known “k-hole effect” and
psychological dissociation symptoms. According to a ketamine uri-
nary analysis for drug abusers in Taiwan, the positive results of ke-
tamine doubled in 8 years (15.4% in 2006 and 31.6% in 2015).1 In
2012, a study in the UK, which used online questionnaires to survey
drug use among 3806 participants via the website, showed that the
prevalence of ketamine use in the last year was 33.8% and 17% of ke-
tamine users were found to be dependent on the drug.2 There is a
selection bias in this study because the study was promoted by a
national dance music magazine and website, and the participants
may not represent the normal population. In fact, the real preva-
lence of ketamine abuse may be underestimated, because the issue
of privacy and the illegal status of ketaminemake it difﬁcult to eval-
uate the undiscovered ketamine-abusing population.3
By contrast, although the World Health Organization concluded
that international control of ketamine is not really necessary, the
drug should be kept under close surveillance.4 The evidence of
increasing ketamine abuse due to its low cost, easy availability to
adolescents, as well as the relatively lenient penalty for ketamine
use demands more stringent laws against the drug. Thus, although
ketamine is now classiﬁed as a class C drug in Taiwan and many
other countries in theworld, the demand for reclassifying ketamine
as a class B drug is increasing.
Ketamine-induced uropathy (KIU) was ﬁrst described in 2007 by
Shahani et al,5 with ﬁndings of ketamine-associated ulcerative
cystitis. Thereafter, multiple cases of KIU were reported, and
20e26.6% of frequent or recent users of ketamine reported experi-
encing urinary symptoms.2,6 In addition, the relationship between
the dosage and frequency of drug use and urinary symptoms has
been shown, however, it was difﬁcult to correlate. Nevertheless, the
diagnosis of KIU remains challenging even today. An increasing num-
ber of patients present to urological services for ketamine-associated
urinary symptoms. General physicians aswell as urologists should be
educatedaboutKIU tomakepatientsawareof thediseaseandprevent
them frompresenting at a relatively later stage.Womenwho present
with pelvic pain similar to the pains caused by pelvic inﬂammatory
disease, ovarian cyst accident, or pressure symptoms from uterine ﬁ-
broidsmay be referred to gynecologists.7 An awareness of KIU should
alsobe spread. Privacy is another issue of diagnosis challengebecause
patients tend to hide or deny the illegal use of ketamine.
KIU can involve both the lower and the upper urinary tract, with
the lower urinary tract being predominantly affected. The diagnosis
of KIU is based on the clinical presentation and a history of keta-
mine use. KIU investigation is essential, and the aims of investi-
gating KIU are as follows: (1) conﬁrming the diagnosis of KIU; (2)http://dx.doi.org/10.1016/j.urols.2015.08.006
1879-5226/Copyright © 2015, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).excluding other causes contributing to the symptoms; (3) evalu-
ating the immediate complications and upper urinary tract involve-
ment; and (4) providing long-term surveillance.7 Among the
investigating tools, image modalities such as computed tomogra-
phy urography (CTU) and rigid cystoscopy are most important.
CTU seems to be superior to rigid cystoscopy because CTU is nonin-
vasive and does not require general anesthesia.
In this review article, the author introduced all the image mo-
dalities for KIU investigation and demonstrated associated imaging
ﬁndings. The image modalities included ultrasound, IVU, and CTU.
These tools can help evaluate both the upper and the lower urinary
tract. Themost common imaging ﬁndings of KIU are reduced capac-
ity of urinary bladder, cystitis, hydronephrosis, and ureteral stric-
ture. Among the image modalities, the author emphasized the
usefulness of CTU and the advantages of split-bolus CTU. Indeed,
CTU can provide detailed information on both the upper and lower
urinary tract by using different reconstruction methods; however,
the traditional three-phase CTU uses a relatively higher radiation
dose compared with split-bolus CTU, which provides information
on tissue perfusion and luminal contrast in the same scan. The
use of split-bolus CTU is recommended for KIU investigation. We
can comprehensively learn the advantages and disadvantages of
each image modality as well as detailed imaging ﬁndings of KIU
from this review. This article provides radiologic knowledge of
KIU to all physicians to make them aware of this disease.
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